{"id":10786,"date":"2022-10-19T15:50:26","date_gmt":"2022-10-19T07:50:26","guid":{"rendered":"https:\/\/clbiomed.com\/?p=10786"},"modified":"2022-10-19T15:50:26","modified_gmt":"2022-10-19T07:50:26","slug":"clb-attends-biomanufacturing-strategy-meeting-europe-2022","status":"publish","type":"post","link":"https:\/\/clbiomed.com\/2022\/10\/clb-attends-biomanufacturing-strategy-meeting-europe-2022\/","title":{"rendered":"CLB attends Biomanufacturing Strategy Meeting Europe 2022"},"content":{"rendered":"
October 11, 2022, Zurich \u2013 As a proud co-sponsor of the Biomanufacturing Strategy Meeting Europe 2022 organized by Proventa, Dr. Tim Calvert, VP of International Markets, Cheerland Biotechnology (CLB), met with executives from major biopharma companies including Novartis, Bayer, Biogen, among other European and US companies. Dr. Calvert introduced to meeting attendees CLB\u2019s current offerings in biologics CDMO services, ranging from large scale commercial CMO to clinical stage PD and CMC.<\/p>\n